Search research articles
Contact Us
Filters
Showing results (11-20 of 298) with videos related to
Page
of 30
Sort By:
Lakartidningen
|
April 10, 1991
[What do we tell our patients about the benefit of anticholesterol treatment?]
H Lithell, B Vessby
International Journal of Obesity
|
January 1, 1978
The lipoprotein-lipase activity of adipose tissue from different sites in obese women and relationship to cell size
H Lithell, J Boberg
Scandinavian Journal of Clinical and Laboratory Investigation
|
October 1, 1977
A method of determining lipoprotein-lipase activity in human adipose tissue
H Lithell, J Boberg
Metabolism: Clinical and Experimental
|
October 1, 1996
Urapidil treatment decreases plasma fibrinogen concentration in essential hypertension
A Haenni, H Lithell
Metabolism: Clinical and Experimental
|
April 1, 1994
Treatment with a beta-blocker with beta 2-agonism improves glucose and lipid metabolism in essential hypertension
A Haenni, H Lithell
Lakartidningen
|
January 30, 1991
[Treatment of hypertension. High safety of first choice agents is a requirement]
B Beermann, H Lithell
Blood Pressure
|
September 1, 1996
Prediction models for insulin resistance
L Berglund, H Lithell
Atherosclerosis
|
May 1, 1990
Interruption of long-term lipid-lowering treatment with bezafibrate in hypertriglyceridaemic patients. Effects on lipoprotein composition, lipase activities and the plasma lipid fatty acid spectrum
B Vessby, H Lithell
Scandinavian Journal of Clinical and Laboratory Investigation
|
April 1, 1994
Angiotensin-converting enzyme in human skeletal muscle. A simple in vitro assay of activity in needle biopsy specimens
R Reneland, H Lithell
Clinical Intensive Care : International Journal of Critical & Coronary Care Medicine
|
December 9, 1993
Impaired glucose and lipid metabolism seen in intensive care patients is related to severity of illness and survival
L Lind, H Lithell
Page
of 30
Search research articles
Search
Showing results (11-20 of 298) with videos related to
Sort By:
Page
of 30
Lakartidningen
|
April 10, 1991
[What do we tell our patients about the benefit of anticholesterol treatment?]
H Lithell, B Vessby
International Journal of Obesity
|
January 1, 1978
The lipoprotein-lipase activity of adipose tissue from different sites in obese women and relationship to cell size
H Lithell, J Boberg
Scandinavian Journal of Clinical and Laboratory Investigation
|
October 1, 1977
A method of determining lipoprotein-lipase activity in human adipose tissue
H Lithell, J Boberg
Metabolism: Clinical and Experimental
|
October 1, 1996
Urapidil treatment decreases plasma fibrinogen concentration in essential hypertension
A Haenni, H Lithell
Metabolism: Clinical and Experimental
|
April 1, 1994
Treatment with a beta-blocker with beta 2-agonism improves glucose and lipid metabolism in essential hypertension
A Haenni, H Lithell
Lakartidningen
|
January 30, 1991
[Treatment of hypertension. High safety of first choice agents is a requirement]
B Beermann, H Lithell
Blood Pressure
|
September 1, 1996
Prediction models for insulin resistance
L Berglund, H Lithell
Atherosclerosis
|
May 1, 1990
Interruption of long-term lipid-lowering treatment with bezafibrate in hypertriglyceridaemic patients. Effects on lipoprotein composition, lipase activities and the plasma lipid fatty acid spectrum
B Vessby, H Lithell
Scandinavian Journal of Clinical and Laboratory Investigation
|
April 1, 1994
Angiotensin-converting enzyme in human skeletal muscle. A simple in vitro assay of activity in needle biopsy specimens
R Reneland, H Lithell
Clinical Intensive Care : International Journal of Critical & Coronary Care Medicine
|
December 9, 1993
Impaired glucose and lipid metabolism seen in intensive care patients is related to severity of illness and survival
L Lind, H Lithell
Page
of 30